| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,387 |
Update - Dividend/Distribution - PGF
|
18 Feb 2026 10:50AM |
$3.200 |
$2.890 |
fallen by
9.69%
|
|
| Judo Capital Holdings Limited (JDO) ORDINARY FULLY PAID |
Financials |
$1,648 |
Dividend/Distribution - JDOPA
|
18 Feb 2026 10:35AM |
$1.835 |
$1.470 |
fallen by
19.89%
|
|
| Qmines Limited (QML) ORDINARY FULLY PAID |
Materials |
$31 |
Connecting Industry Presentation
|
18 Feb 2026 10:30AM |
$0.053 |
$0.048 |
fallen by
9.43%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$400 |
CRML Reports Hill Deposit Core Resampling Results Tanbreez
|
18 Feb 2026 10:26AM |
$0.225 |
$0.230 |
risen by
2.22%
|
|
| Sports Entertainment Group Limited (SEG) ORDINARY FULLY PAID |
Communication Services |
$69 |
Half Year FY26 Results Announcement
|
18 Feb 2026 10:21AM |
$0.275 |
$0.245 |
fallen by
10.91%
|
|
SEG - Price-sensitive ASX Announcement
Full Release
Key Points
- SEG's revenue increased by 28% to $73.7 million.
- EBITDA grew by 94% to $9.7 million.
- Strong performance from Complementary Services and Media segments.
- Declared 1.0 cent per share fully franked ordinary interim dividend.
- Declared 3.0 cent per share fully franked special dividend.
- SEG remains in a net cash positive position.
- Further positive operating cash flow expected in H2 FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| New Murchison Gold Limited (NMG) ORDINARY FULLY PAID |
Materials |
$521 |
CEO Presentation to RIU Conference
|
18 Feb 2026 10:21AM |
$0.059 |
$0.048 |
fallen by
18.64%
|
|
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,392 |
BKI DRP Price and DRP Neutralisation Update
|
18 Feb 2026 10:20AM |
$1.735 |
$1.725 |
fallen by
0.58%
|
|
| Sports Entertainment Group Limited (SEG) ORDINARY FULLY PAID |
Communication Services |
$69 |
Dividend/Distribution - SEG
|
18 Feb 2026 10:20AM |
$0.275 |
$0.245 |
fallen by
10.91%
|
|
| Sports Entertainment Group Limited (SEG) ORDINARY FULLY PAID |
Communication Services |
$69 |
Half Year FY26 Financial Report
|
18 Feb 2026 10:20AM |
$0.275 |
$0.245 |
fallen by
10.91%
|
|
SEG - Price-sensitive ASX Announcement
Full Release
Key Points
- Sports Entertainment Group Limited (SEG) reported an increase in revenue from ordinary activities, rising by 28% to AUD 73.671 million for the period ending 31 December 2025.
- SEG's underlying EBITDA from continuing operations increased by 78% to AUD 11.945 million.
- The profit from continuing operations after tax improved significantly to AUD 3.243 million, from a loss of AUD 456,000 in the previous period.
- SEG completed the acquisition of 3UZ Pty Ltd's assets, valued at AUD 3.25 million, contributing AUD 858,816 in revenue.
- The company's net assets as of 31 December 2025 stood at AUD 74.71 million, with total equity rising to AUD 74.71 million from AUD 73.514 million.
- SEG declared a fully franked dividend paid in September 2025 for the period ending 30 June 2025.
- SEG's cash and cash equivalents increased significantly to AUD 26.716 million from AUD 14.955 million at the start of the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$19 |
1HFY26 Results Presentation
|
18 Feb 2026 10:14AM |
$0.043 |
$0.044 |
risen by
2.33%
|
|
IDT - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic realignment under new leadership led to earnings recovery with an increase in EBITDA.
- Revenue growth primarily driven by the API Manufacturing and Specialty Orals businesses.
- Annualized cost savings target increased to $2M from the original $1M.
- Operating revenue from three business verticals rose to $8.4M, marking a 20.3% increase from the previous comparative period.
- Operating expenses reduced due to resource reallocation and automation benefits.
- A positive outlook for the full year with further gains expected from strategic initiatives.
- IDT is Australia's first mRNA vaccine manufacturer with significant growth in mRNA and radiopharmaceutical sectors.
- API Manufacturing reestablished as the foundation for growth and targeting follow-on contracts.
- Strategic focus on high-demand areas like radiopharmaceuticals and mRNA innovations.
- Operating leverage benefits expected from streamlined operations and resource reallocations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$19 |
1HFY26 Results
|
18 Feb 2026 10:13AM |
$0.043 |
$0.044 |
risen by
2.33%
|
|
IDT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from core verticals increased by 20.3% to $8.4 million.
- EBITDA improved by $2.3 million to a loss of $436k.
- API manufacturing revenue increased by 191.4%.
- Operating expenses reduced by 14.2%, with cost savings forecast increased to $2 million.
- Strategic focus on leveraging GMP-certified offerings for growth.
- Positive outlook and solid pipeline for 2HFY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atturra Limited (ATA) ORDINARY FULLY PAID |
Information Technology |
$208 |
H1 FY26 Financial Results Date & Investor Webinar
|
18 Feb 2026 10:13AM |
$0.595 |
$0.560 |
fallen by
5.88%
|
|
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$19 |
1HFY26 Appendix 4D and Half Year Report
|
18 Feb 2026 10:12AM |
$0.043 |
$0.044 |
risen by
2.33%
|
|
IDT - Price-sensitive ASX Announcement
Full Release
Key Points
- Reduction in loss before tax by 59.5% to $1.3 million.
- Stable revenue at $9.8 million.
- Operating cash inflows of $1.6 million.
- Cash balance of $1.9 million by end of the period.
- Growth in Active Pharmaceutical Ingredient manufacturing by 191.4% to $3 million.
- Growth in Specialty Orals by 26% to $2.5 million.
- Decline in Advanced Therapies revenue to $2.9 million due to customer timing.
- Increased operational efficiencies and cost-saving initiatives.
- No dividends declared or paid during the period.
- Audit review found no disputes or qualifications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tower Limited (TWR) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$517 |
Michael Stiassny retires, Naomi Ballantyne elected as Chair
|
18 Feb 2026 10:09AM |
$1.530 |
$1.505 |
fallen by
1.63%
|
|
| 29Metals Limited (29M) ORDINARY FULLY PAID |
Materials |
$629 |
Change in substantial holding
|
18 Feb 2026 10:09AM |
$0.410 |
$0.360 |
fallen by
12.20%
|
|
| Tower Limited (TWR) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$517 |
Results of Annual Shareholder Meeting
|
18 Feb 2026 10:09AM |
$1.530 |
$1.505 |
fallen by
1.63%
|
|
| Castile Resources Ltd (CST) ORDINARY FULLY PAID |
Materials |
$35 |
Change in substantial holding
|
18 Feb 2026 10:06AM |
$0.100 |
$0.091 |
fallen by
9%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$297 |
Dividend/Distribution - SVR
|
18 Feb 2026 10:04AM |
$1.760 |
$1.570 |
fallen by
10.80%
|
|
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$15 |
Change of Director's Interest Notice - Niv Dagan
|
18 Feb 2026 10:00AM |
$0.085 |
$0.100 |
risen by
17.65%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$297 |
Solvar H1 FY26 Investor Presentation
|
18 Feb 2026 9:58AM |
$1.760 |
$1.570 |
fallen by
10.80%
|
|
SVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Stable bad debts and significant funding headroom for Solvar.
- New $488 million Money3 facility established, resizing existing to $270 million.
- 82% of the Australian portfolio rated 'Strong and Good'.
- Increased contribution from Bennji and AFS expected to improve loan book quality.
- Forecast normalised NPAT of $36 million for FY26.
- Plans to maintain dividend payout ratio in H2 FY26.
- Solvar is exiting New Zealand, with New Zealand operations contributing less than 10% of interest income.
- Ongoing expansion in commercial lending and Bennji business.
- Loan book quality expected to improve with diversified funding and strategic business unit contributions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$68 |
Proposed issue of securities - PHO
|
18 Feb 2026 9:57AM |
$0.145 |
$0.130 |
fallen by
10.34%
|
|
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$15 |
Proposed issue of securities - T92
|
18 Feb 2026 9:57AM |
$0.085 |
$0.100 |
risen by
17.65%
|
|
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$68 |
Strongly Supported $5M Placement
|
18 Feb 2026 9:57AM |
$0.145 |
$0.130 |
fallen by
10.34%
|
|
PHO - Price-sensitive ASX Announcement
Full Release
Key Points
- PhosCo secured $5 million through a share placement at $0.12 per share.
- Strong demand from institutional investors and existing shareholders.
- Funds will support exploration and development of the Gasaat Project in Tunisia.
- Placement funds to aid in scoping and feasibility studies.
- Settlement of shares expected on 25 February 2026.
- Shares to rank equally with existing PhosCo shares on ASX.
- Argonaut Securities and Cumulus Wealth were joint lead managers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeris Resources Limited (AIS) ORDINARY FULLY PAID |
Materials |
$503 |
CLARIFICATION & RETRACTION - PEEL ACQUISITION ANNOUNCEMENTS
|
18 Feb 2026 9:57AM |
$0.515 |
$0.420 |
fallen by
18.45%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$297 |
Solvar H1 FY26 Results
|
18 Feb 2026 9:57AM |
$1.760 |
$1.570 |
fallen by
10.80%
|
|
SVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Normalised NPAT of $20.0 million, a 5.8% increase.
- Statutory NPAT of $17.8 million.
- Earnings per share increased by 13.5% to 9.3 cents.
- Fully franked interim and special dividends declared totaling 8.5 cents.
- Australian loan book grew by 1.7% to $846.6 million.
- Bad debt expense reduced by $6.2 million due to New Zealand loan book sale.
- Over $500.0 million in funding headroom available.
- Sold New Zealand written-off loan book for NZ$9.4 million.
- Increased funding sources with a new $488.0 million debt facility.
- Commercial loan book is expanding with expected continued growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.